Enzalutamide
Pfizer,Astellas
[]
 exciting! i will add that with the lower cost of wgs , it makes sense to perform tumor wgs and to use mutational signature to identify hrd tumors instead of the current hrr genes sequencing focused approached. no?
VP of Computational Biology at C2i Genomics. Views are my own